$SWKH
SWK Holdings Corp

2023 Q4 Form 10-Q Financial Statement

#000155278123000439 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $9.890M $8.962M
YoY Change 0.95% -34.17%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.087M $3.200M
YoY Change -14.19% -26.42%
% of Gross Profit
Research & Development $602.0K $606.0K
YoY Change -66.16% -66.18%
% of Gross Profit
Depreciation & Amortization $637.0K $650.0K
YoY Change 0.31% 2.52%
% of Gross Profit
Operating Expenses $6.329M $606.0K
YoY Change -24.13% -66.18%
Operating Profit $4.326M
YoY Change -35.98%
Interest Expense $5.454M $176.0K
YoY Change -193.49% 114.63%
% of Operating Profit 4.07%
Other Income/Expense, Net
YoY Change
Pretax Income $611.0K $4.088M
YoY Change -113.95% -52.23%
Income Tax -$2.233M -$386.0K
% Of Pretax Income -365.47% -9.44%
Net Earnings $2.844M $4.474M
YoY Change 0.42% -32.38%
Net Earnings / Revenue 28.76% 49.92%
Basic Earnings Per Share $0.36
Diluted Earnings Per Share $0.23 $0.36
COMMON SHARES
Basic Shares Outstanding 12.50M shares 12.54M shares
Diluted Shares Outstanding 12.58M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.503M $31.00M
YoY Change -26.85% 55.79%
Cash & Equivalents $4.503M $31.03M
Short-Term Investments
Other Short-Term Assets $1.904M $1.756M
YoY Change 70.92% 47.69%
Inventory
Prepaid Expenses
Receivables $4.729M $4.400M
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.87M $37.20M
YoY Change 14.52% 30.66%
LONG-TERM ASSETS
Property, Plant & Equipment $5.438M $5.479M
YoY Change -6.88% -7.84%
Goodwill $8.404M
YoY Change 0.0%
Intangibles $6.487M $6.913M
YoY Change -20.79% -19.76%
Long-Term Investments $48.00K $100.0K
YoY Change -36.84% -97.21%
Other Assets $3.109M $4.057M
YoY Change 78.47% 125.14%
Total Long-Term Assets $322.4M $278.6M
YoY Change 11.45% 5.63%
TOTAL ASSETS
Total Short-Term Assets $11.87M $37.20M
Total Long-Term Assets $322.4M $278.6M
Total Assets $334.3M $315.8M
YoY Change 11.56% 8.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.935M $2.700M
YoY Change 0.85% -43.11%
Accrued Expenses
YoY Change
Deferred Revenue $9.000K
YoY Change
Short-Term Debt $0.00 $22.00M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.944M $24.77M
YoY Change -37.86% 421.87%
LONG-TERM LIABILITIES
Long-Term Debt $43.13M $0.00
YoY Change
Other Long-Term Liabilities $1.964M $2.312M
YoY Change -8.44% 49.74%
Total Long-Term Liabilities $1.964M $2.312M
YoY Change -8.44% 49.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.944M $24.77M
Total Long-Term Liabilities $1.964M $2.312M
Total Liabilities $53.94M $38.28M
YoY Change 173.91% 158.3%
SHAREHOLDERS EQUITY
Retained Earnings -$4.145B -$4.148B
YoY Change -0.15% -0.15%
Common Stock $12.00K $12.00K
YoY Change 0.0% -7.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $280.3M $277.6M
YoY Change
Total Liabilities & Shareholders Equity $334.3M $315.8M
YoY Change 11.56% 8.07%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $2.844M $4.474M
YoY Change 0.42% -32.38%
Depreciation, Depletion And Amortization $637.0K $650.0K
YoY Change 0.31% 2.52%
Cash From Operating Activities $5.697M $3.800M
YoY Change 84.07% 121.96%
INVESTING ACTIVITIES
Capital Expenditures $196.0K $110.0K
YoY Change 90.29% -232.53%
Acquisitions
YoY Change
Other Investing Activities -$52.32M -$30.00K
YoY Change 234.52% -99.92%
Cash From Investing Activities -$52.52M -$140.0K
YoY Change 233.57% -99.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 21.02M 20.57M
YoY Change -3638.72% -2810.14%
NET CHANGE
Cash From Operating Activities 5.697M 3.800M
Cash From Investing Activities -52.52M -140.0K
Cash From Financing Activities 21.02M 20.57M
Net Change In Cash -25.80M 24.23M
YoY Change 94.83% -167.84%
FREE CASH FLOW
Cash From Operating Activities $5.697M $3.800M
Capital Expenditures $196.0K $110.0K
Free Cash Flow $5.501M $3.690M
YoY Change 83.86% 105.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001089907
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
usd
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
usd
us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
usd
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39184
dei Entity Registrant Name
EntityRegistrantName
SWK Holdings Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0435679
dei Entity Address Address Line1
EntityAddressAddressLine1
5956 Sherry Lane
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75225
dei City Area Code
CityAreaCode
972
dei Local Phone Number
LocalPhoneNumber
687-7250
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12503113 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31034000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6156000 usd
CY2023Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
4411000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3094000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1756000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1114000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
37201000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
10364000 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
11327000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
11846000 usd
CY2023Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
223604000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
236555000 usd
CY2023Q3 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
2750000 usd
CY2022Q4 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
2750000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
50000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
76000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
26090000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
24480000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6913000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8190000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
8404000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
8404000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5479000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5840000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4057000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1742000 usd
CY2023Q3 us-gaap Assets
Assets
315845000 usd
CY2022Q4 us-gaap Assets
Assets
299621000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2768000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3902000 usd
CY2023Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
22000000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2445000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
24768000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6347000 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
11200000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
11200000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2312000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2145000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
38280000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
19692000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12510776 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12510776 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12843157 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12843157 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
12000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4425198000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4430922000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4147645000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4151005000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
277565000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
279929000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
315845000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
299621000 usd
CY2023Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
8608000 usd
CY2022Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
8502000 usd
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
27146000 usd
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
25745000 usd
CY2023Q3 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
39000 usd
CY2022Q3 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
1000 usd
us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
108000 usd
us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
481000 usd
CY2023Q3 us-gaap Revenues
Revenues
8962000 usd
CY2022Q3 us-gaap Revenues
Revenues
13614000 usd
us-gaap Revenues
Revenues
27870000 usd
us-gaap Revenues
Revenues
31687000 usd
CY2023Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
223000 usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-459000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
176000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
82000 usd
us-gaap Interest Expense
InterestExpense
721000 usd
us-gaap Interest Expense
InterestExpense
242000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
606000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1792000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2834000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5173000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
652000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
634000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1937000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1964000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2979000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4349000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8516000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10527000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
-4326000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
-6757000 usd
us-gaap Costs And Expenses
CostsAndExpenses
-14321000 usd
us-gaap Costs And Expenses
CostsAndExpenses
-13781000 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-162000 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1788000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-745000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
623000 usd
CY2022Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
13000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-534000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
-76000 usd
us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
426000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4088000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8558000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14002000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13870000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-386000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1942000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
959000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3211000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
4474000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
6616000 usd
us-gaap Profit Loss
ProfitLoss
13043000 usd
us-gaap Profit Loss
ProfitLoss
10659000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12539000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12832000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12703000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12832000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12582000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12851000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12746000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12871000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
279929000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
35000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
531000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4635000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
274385000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
164000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4599000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3934000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
273884000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
170000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
963000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
4474000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
277565000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
267236000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
85000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3478000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
270799000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
166000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
565000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
271530000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
59000 usd
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
599000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
6616000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
277446000 usd
us-gaap Profit Loss
ProfitLoss
13043000 usd
us-gaap Profit Loss
ProfitLoss
10659000 usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-459000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
244000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
171000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
243000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
26000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
915000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
3189000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
745000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-623000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-534000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-375000 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
2959000 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
1357000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
1826000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
3335000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
369000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
310000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1937000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1964000 usd
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
1317000 usd
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
5581000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
738000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
76000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-635000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-603000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9187000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5278000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
13942000 usd
us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
17525000 usd
us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
71750000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
299000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
194000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3574000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27975000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1345000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
19555000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-8000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6093000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
599000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12117000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-767000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24878000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23464000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6156000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42863000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31034000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19399000 usd
CY2023Q3 dei Entity Number Of Employees
EntityNumberOfEmployees
23 number
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zzNurlJPFBWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_861_zsTnEHOWFzXh">Use of Estimates</span></i></b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are required in the determination of revenue recognition; stock-based compensation; valuation of interest and accounts receivable; impairment of finance receivables; allowance for credit losses; long-lived assets; property and equipment; intangible assets; goodwill; valuation of warrants and other investments; contingent consideration; income taxes; and contingencies and litigation, among others. Some of these judgments can be subjective and complex, and consequently, actual results may differ from these estimates. The Company’s estimates often are based on complex judgments, probabilities and assumptions that it believes to be reasonable but that are inherently uncertain and unpredictable. For any given individual estimate or assumption made by the Company, there may also be other estimates or assumptions that are reasonable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The Company regularly evaluates its estimates and assumptions using historical experience and other factors, including the economic environment. As future events and their effects cannot be determined with precision, the Company’s estimates and assumptions may prove to be incomplete or inaccurate, or unanticipated events and circumstances may occur that might cause changes to those estimates and assumptions. Market conditions, such as illiquid credit markets, health crises such as the COVID-19 global pandemic, volatile equity markets, and economic downturns, can increase the uncertainty already inherent in the Company’s estimates and assumptions. The Company adjusts its estimates and assumptions when facts and circumstances indicate the need for change. Those changes generally will be reflected in our consolidated financial statements on a prospective basis unless they are required to be treated retrospectively under the relevant accounting standard. It is possible that other professionals, applying reasonable judgment to the same facts and circumstances, could develop and support a range of alternative estimated amounts.</span></p>
CY2023Q3 us-gaap Profit Loss
ProfitLoss
4474000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
6616000 usd
us-gaap Profit Loss
ProfitLoss
13043000 usd
us-gaap Profit Loss
ProfitLoss
10659000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12539000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12832000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12703000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12832000 shares
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
43000 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
19000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
43000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
39000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12582000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12851000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12746000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12871000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
127000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
186000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
121000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
268000 shares
CY2023Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
234931000 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
248401000 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
11327000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
11846000 usd
CY2023Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
223604000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
236555000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
11846000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8388000 usd
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
11846000 usd
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
31000 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
11786000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-459000 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
11327000 usd
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8357000 usd
CY2023Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
234931000 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
248401000 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
11327000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
11846000 usd
CY2023Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
223604000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
236555000 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
9957000 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
76535000 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
49658000 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
29109000 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
37644000 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
32028000 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
234931000 usd
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
29850000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22937000 usd
CY2023Q3 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
6913000 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
29850000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21660000 usd
CY2022Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
8190000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1300000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
426000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1546000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1076000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1076000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1076000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1713000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6913000 usd
CY2022Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
2400000 usd
CY2023Q3 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
11200000000 usd
CY2022Q4 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
11200000000 usd
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
30000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
33000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
30000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
33000 usd
CY2023Q3 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
39000 usd
CY2023Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
223000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
176000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
606000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
652000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2979000 usd
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-238000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-386000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
4474000 usd
CY2022Q3 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
1000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
82000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1792000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
634000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4349000 usd
CY2022Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1801000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1942000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
6616000 usd
us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
108000 usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-459000 usd
us-gaap Interest Expense
InterestExpense
721000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2834000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1937000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8516000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-319000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
959000 usd
us-gaap Profit Loss
ProfitLoss
13043000 usd
us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
481000 usd
us-gaap Interest Expense
InterestExpense
242000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5173000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1964000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10527000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
89000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3211000 usd
us-gaap Profit Loss
ProfitLoss
10659000 usd

Files In Submission

Name View Source Status
swkh-20230930_cal.xml Edgar Link unprocessable
0001552781-23-000439-index-headers.html Edgar Link pending
0001552781-23-000439-index.html Edgar Link pending
0001552781-23-000439.txt Edgar Link pending
0001552781-23-000439-xbrl.zip Edgar Link pending
e23436001.jpg Edgar Link pending
e23436_swkh-10q.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
e23436_swkh-10q_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
swkh-20230930.xsd Edgar Link pending
swkh-20230930_def.xml Edgar Link unprocessable
swkh-20230930_lab.xml Edgar Link unprocessable
swkh-20230930_pre.xml Edgar Link unprocessable